23
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Antidepressant Active Components of Bupleurum chinense DC-Paeonia lactiflora Pall Herb Pair: Pharmacological Mechanisms

      review-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Depression is a serious psychological disorder with a rapidly increasing incidence in recent years. Clinically, selective serotonin reuptake inhibitors are the main therapy. These drugs, have serious adverse reactions, however. Traditional Chinese medicine has the characteristics of multiple components, targets, and pathways, which has huge potential advantages for the treatment of depression. The antidepressant potential of the herbal combination of Bupleurum chinense DC (Chaihu) and Paeonia lactiflora Pall (Baishao) has been extensively studied previously. In this review, we summarized the antidepressant active components and mechanism of Chaihu-Baishao herb pair. We found that it works mainly through relieving oxidative stress, regulating HPA axis, and protecting neurons. Nevertheless, current research of this combined preparation still faces many challenges. On one hand, most of the current studies only stay at the level of animal models, lacking of sufficient clinical double-blind controlled trials for further verification. In addition, studies on the synergistic effect between different targets and signaling pathways are scarce. On the other hand, this preparation has numerous defects such as poor stability, low solubility, and difficulty in crossing the blood-brain barrier.

          Related collections

          Most cited references85

          • Record: found
          • Abstract: found
          • Article: not found

          Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants.

          Depression is a common, devastating illness. Current pharmacotherapies help many patients, but high rates of a partial response or no response, and the delayed onset of the effects of antidepressant therapies, leave many patients inadequately treated. However, new insights into the neurobiology of stress and human mood disorders have shed light on mechanisms underlying the vulnerability of individuals to depression and have pointed to novel antidepressants. Environmental events and other risk factors contribute to depression through converging molecular and cellular mechanisms that disrupt neuronal function and morphology, resulting in dysfunction of the circuitry that is essential for mood regulation and cognitive function. Although current antidepressants, such as serotonin-reuptake inhibitors, produce subtle changes that take effect in weeks or months, it has recently been shown that treatment with new agents results in an improvement in mood ratings within hours of dosing patients who are resistant to typical antidepressants. Within a similar time scale, these new agents have also been shown to reverse the synaptic deficits caused by stress.
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Quercetin, Inflammation and Immunity

            In vitro and some animal models have shown that quercetin, a polyphenol derived from plants, has a wide range of biological actions including anti-carcinogenic, anti-inflammatory and antiviral activities; as well as attenuating lipid peroxidation, platelet aggregation and capillary permeability. This review focuses on the physicochemical properties, dietary sources, absorption, bioavailability and metabolism of quercetin, especially main effects of quercetin on inflammation and immune function. According to the results obtained both in vitro and in vivo, good perspectives have been opened for quercetin. Nevertheless, further studies are needed to better characterize the mechanisms of action underlying the beneficial effects of quercetin on inflammation and immunity.
              • Record: found
              • Abstract: found
              • Article: not found

              Neuronal Cell Death.

              Neuronal cell death occurs extensively during development and pathology, where it is especially important because of the limited capacity of adult neurons to proliferate or be replaced. The concept of cell death used to be simple as there were just two or three types, so we just had to work out which type was involved in our particular pathology and then block it. However, we now know that there are at least a dozen ways for neurons to die, that blocking a particular mechanism of cell death may not prevent the cell from dying, and that non-neuronal cells also contribute to neuronal death. We review here the mechanisms of neuronal death by intrinsic and extrinsic apoptosis, oncosis, necroptosis, parthanatos, ferroptosis, sarmoptosis, autophagic cell death, autosis, autolysis, paraptosis, pyroptosis, phagoptosis, and mitochondrial permeability transition. We next explore the mechanisms of neuronal death during development, and those induced by axotomy, aberrant cell-cycle reentry, glutamate (excitoxicity and oxytosis), loss of connected neurons, aggregated proteins and the unfolded protein response, oxidants, inflammation, and microglia. We then reassess which forms of cell death occur in stroke and Alzheimer's disease, two of the most important pathologies involving neuronal cell death. We also discuss why it has been so difficult to pinpoint the type of neuronal death involved, if and why the mechanism of neuronal death matters, the molecular overlap and interplay between death subroutines, and the therapeutic implications of these multiple overlapping forms of neuronal death.

                Author and article information

                Contributors
                Journal
                Biomed Res Int
                Biomed Res Int
                BMRI
                BioMed Research International
                Hindawi
                2314-6133
                2314-6141
                2022
                9 November 2022
                : 2022
                : 1024693
                Affiliations
                1College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan 250355, China
                2School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China
                3School of Management, Shandong University of Traditional Chinese Medicine, Jinan 250355, China
                4Department of Radiology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200000, China
                5Preventive Treatment Center, Shenzhen Integrated Traditional Chinese and Western Medicine Hospital, Shenzhen 518027, China
                6Zhongshan Torch Development Zone People's Hospital, Zhongshan 528400, China
                7Department of Pharmacy, Zhongshan Hospital of Traditional Chinese Medicine, Zhongshan 528400, China
                8School of Foreign Language, Shandong University of Traditional Chinese Medicine, Jinan 250355, China
                9Experimental Center, Shandong University of Traditional Chinese Medicine, Jinan 250355, China
                10Innovation Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China
                Author notes

                Academic Editor: Si Qin

                Author information
                https://orcid.org/0000-0003-0607-7028
                https://orcid.org/0000-0003-0869-5479
                https://orcid.org/0000-0002-8877-4996
                https://orcid.org/0000-0002-3122-6251
                https://orcid.org/0000-0001-9740-9109
                https://orcid.org/0000-0001-5141-5941
                https://orcid.org/0000-0002-3130-1733
                https://orcid.org/0000-0002-5149-9994
                https://orcid.org/0000-0002-5859-7685
                https://orcid.org/0000-0002-6114-138X
                https://orcid.org/0000-0003-4117-4165
                Article
                10.1155/2022/1024693
                9668458
                36408279
                82ffb9f7-0b53-4b85-8277-8fe710c2e48d
                Copyright © 2022 Shimeng Lv et al.

                This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 23 August 2022
                : 15 October 2022
                Funding
                Funded by: Youth Research and Innovation Team of TCM-Based Neuroimmune Pharmacology, University of Shandong Traditional Chinese Medicine
                Award ID: 22202112
                Funded by: Shandong Major Innovation Project
                Award ID: 2022CXGC020514
                Funded by: Central Government Guided Local Science and Technology Development Project
                Award ID: 22-1-3-11-zyyd-nsh-3
                Funded by: Natural Science Foundation of Shandong Province
                Award ID: ZR2020MB108
                Award ID: ZR2019MH063
                Funded by: National Health Commission of the People's Republic of China
                Award ID: 2017ZX09301064
                Award ID: 2017ZX09301064002
                Funded by: National Natural Science Foundation of China
                Award ID: 81874419
                Award ID: 81673719
                Award ID: 81303074
                Categories
                Review Article

                Comments

                Comment on this article

                Related Documents Log